Stock market today: Dow, S&P 500, Nasdaq futures climb after Wall Street's latest tech sell-off
US stock futures held on just in the green on Friday, hinting at a modest rebound from a steep tech-led sell-off as investors weighed signals on the jobs market and the odds of overdone AI valuations.
Futures on the Dow Jones Industrial Average (YM=F) and the S&P 500 (ES=F) hovered just above the flat line,
Read MoreThese 3 Stocks Have Been the S&P 500's Hottest Buys This Year. Can They Still Go Higher?
These stocks listed here have risen between 225% and 275% this year.
The S&P 500 has risen 16% this year, as it flirts with a third-straight year of 20% gains. It would be an impressive feat for the market. But that still pales in comparison to how well three of the hottest stocks on the index have performed.
Motley Fool: Blue-chip dividends and growth
The Vanguard Dividend Appreciation ETF (ticker: VIG) is chock-full of blue-chip companies. It aims to roughly duplicate the performance of the S&P U.S. Dividend Growers Index – which features companies with at least 10 consecutive years of dividend increases – by holding most or all of the same companies. (The index also excludes the topyielding quarter of eligible stocks to avoid yield traps – situations where a stock has a high dividend yield simply because its stock price has fallen,
» Read more about: Motley Fool: Blue-chip dividends and growth »
Read MoreAppointment of 'politically exposed persons' to PSU boards faces pushback from mutual funds
Despite the dissenting votes, all such resolutions were ultimately approved owing to the government’s dominant shareholding in these undertakings.
A growing number of mutual funds managing over Rs 11 lakh crore in assets are opposing the appointment of Politically Exposed Persons (PEPs) on the boards of listed public sector undertakings,
Read MoreYour Money Minute: Earn, save, invest
More money doesn’t always solve money problems. Many Americans feel financially broke despite their income levels. A recent study revealed that 46% of Americans spend significantly on clothing, shoes, and beauty treatments each month, while ther personal saving rate in the United States hovers at a mere 4.5%. This disparity raises important questions about the spending habits and financial priorities.
» Read more about: Your Money Minute: Earn, save, invest »
Read MoreThe Burst
The Future of Technology In 2026 and Beyond
Over the past decade, the tech sector has tended to rebound after bouts of underperformance, about 80% of the time, historically. This year looked like another chapter in that same story: short-term skepticism giving way to renewed conviction.
Now, as we move into the final quarter of 2025, several massive forces are quietly re-shaping the landscape.
» Read more about: The Future of Technology In 2026 and Beyond »
Read MoreThe Ivy
Ken Griffin’s Big Trim in Palantir
In the second quarter of 2025, Ken Griffin’s Citadel Advisors sharply reduced its holding in Palantir Technologies, selling nearly half of its position.
The move raised about $75 million in cash and followed a familiar pattern for Griffin, who has been building and trimming his Palantir stake in waves since 2021.
This latest sale has investors wondering: why would one of Wall Street’s most sophisticated fund managers cut exposure to a stock riding the artificial intelligence boom?
» Read more about: Ken Griffin’s Big Trim in Palantir »
Read MoreThe Spotlight
Why Novo May Be the Real Winner in Obesity Drug Boom
For decades, Novo Nordisk was known mainly within the medical community as a quiet Danish powerhouse in diabetes care. Fast-forward to today, and its brand names are practically pop culture references. Wegovy and Ozempic have become synonymous with rapid weight loss, with late-night comedians, TikTok influencers, and even Hollywood scripts weaving them into conversation. Yet the company’s stock,
» Read more about: Why Novo May Be the Real Winner in Obesity Drug Boom »